Navigation Links
Genaera Corporation's 2008 Annual Stockholder Meeting Results
Date:5/30/2008

PLYMOUTH MEETING, Pa., May 30 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced the results of its Annual Meeting of Stockholders held on May 29, 2008. Proxies representing a majority of the shares voted at the Annual Meeting were cast in favor of the resolutions brought before the stockholders.

As a result, at the meeting:

-- John L. Armstrong, Jr., R. Frank Ecock, Zola P. Horovitz, Ph.D.,

Mitchell D. Kaye, Osagie O. Imasogie and Robert F. Shapiro were all

re-elected to the Company's Board of Directors;

-- Genaera's 2004 Stock-Based Incentive Compensation Plan was amended to

provide for an increased number of shares issuable thereunder; and

-- KPMG LLP was appointed as the Company's independent registered public

accounting firm for the fiscal year ending December 31, 2008.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a phase 1 trial in obesity. In addition, Genaera has a value-driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.

This announcement contains forward-looking statements w
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Xmark Comments on Genaera Cost-Saving Plan
2. Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph
3. Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
4. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
5. Nationally Recognized Corporations and Retailers Rally Behind breastcancer.org
6. Rivaroxaban phase III pivotal data presented at EFORT annual meeting
7. NYP/Columbia physician-scientists present at ASCO 44th annual meeting
8. AMERIGROUP Corporation to Present at the Goldman Sachs 29th Annual Global Healthcare Conference on June 11
9. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
10. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
11. Longs Drug Stores Corporation Announced at Its Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Dinner preparation and meal planning have ... of DinnerDork , a company that specializes ... thousands of busy customers. The company recently responded ... offer a total of 6 diverse meal plan ... recipes and comfort foods; Paleo Palette, which caters ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
(Date:3/2/2015)... 2015 A true renaissance man—some might call ... 1960s cult rock band Khazad Doom, has long inspired his ... persevere despite all odds. His motto throughout his life has ... or goal was before him. And that attitude, born amidst ... passed on to a new generation. , As Eadon knows, ...
(Date:3/2/2015)... Houston, TX (PRWEB) March 02, 2015 ... CV? How should physicians request references? When are interviews ... physicians analyze employment opportunities?, Both training and practicing physicians ... answers to these questions and more at the PracticeLink ... March 18. The drop-in Job Fair is from 5:30 ...
(Date:3/2/2015)... Many mainstream media outlets have run ... But how much of that news reporting is true? ... prevent measles, but whose youngsters later developed autism, will ... speakers comprised of professionals, clinicians, researchers, therapists, advocates, and ... and questions about the body and childhood health will ...
Breaking Medicine News(10 mins):Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 2Health News:DinnerDork Announces New Meal Planning Support for the Home Cook 3Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Growing List of Professionals Gather for World’s Most Comprehensive Autism Conference in Chicago, May 2015 2
... professor of pharmacology and a member of UNC Lineberger ... Innovative Research Grants from Stand Up to Cancer, the ... The grants were announced during an event at ... Meeting 2011. SU2C,s Innovative Research Grants Program, which ...
... University of California, San Diego School of Medicine say a ... harsh or demanding conditions is exploited by cancer cells, which ... inflammatory response in them that can aid tumor growth. ... medicine and director of the Laboratory of Immunology at the ...
... 4 (HealthDay News) -- A minimally invasive treatment for ... among seniors -- appears to be as effective as ... take about two hours to perform, the newer alternative ... a catheter-enabled insertion of a tiny clothespin-like device, called ...
... of Medicine,s Cosimo Commisso, PhD, a postdoctoral fellow in ... The Pancreatic Cancer Action Network-American Association for Cancer Research ... research. Dr. Commisso was honored at the American Association ... 2-6, in Orlando, Florida. Dr. Commisso will receive ...
... that reign during relapses of an aggressive human leukemia are ... a paper published online on April 4 in the ... By comparing the DNA of cancer cells taken at the ... acute lymphoblastic leukemia (T-ALL), Jean Soulier and co-workers found that ...
... calculator can predict the risk of postoperative complications occurring for ... the March issue of the Journal of the American ... surgical decision-making and will help patients better understand what they ... bariatric operation. The study authors developed the risk ...
Cached Medicine News:Health News:Call of the riled 2Health News:Clamp Device for Leaky Heart Valve Seems Effective 2Health News:Clamp Device for Leaky Heart Valve Seems Effective 3Health News:NYU School of Medicine researcher receives Pancreatic Cancer Action Network- AACR fellowship 2Health News:New tool helps surgeons predict patients' risk of complications after bariatric operations 2
(Date:3/2/2015)... Mount Elizabeth Novena Hospital will soon become the first ... treat cancer using the TrueBeam™ STx system for radiotherapy ... VAR ).  At a Grand Opening event last Friday, ... of treatment including radiosurgery, a precise method of using ... from outside the body, without performing surgery.  ...
(Date:3/2/2015)... -- Valencia Technologies Corporation (" Valencia ") ... small device for the treatment of high blood pressure ... double-blinded, controlled trial are compelling and provide the Company ... succeed in a large U.S. trial for FDA approval. ... Valencia has successfully raised more than 2.2 ...
(Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
Breaking Medicine Technology:Mount Elizabeth Novena Hospital to Deliver First TrueBeam STx Radiosurgery Treatments in Singapore 2Mount Elizabeth Novena Hospital to Deliver First TrueBeam STx Radiosurgery Treatments in Singapore 3Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3
... OAKLAND, Tenn., Feb. 23, 2011 Plexus Biomedical Inc. ... the Food and Drug Administration to market the first ... vaginal childbirth. Hemorrhoids associated with vaginal delivery are a ... 1,000,000 pregnant women in the U.S. every year. ...
... 2011 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... investor conferences in March: Citi,s 2011 Global Healthcare Conference , ... Capital Markets, Healthcare Conference , Thursday, March 3, at ... Healthcare Conference , Wednesday, March 9, at 10:15 a.m. ET ...
Cached Medicine Technology:Plexus Biomedical Inc. Gains FDA Approval of the First Medical Device to Help Prevent External Hemorrhoids During Vaginal Childbirth 2
Built-in convexity means added security and skin protection for recessed, retracted and flush stomas...pre-cut openings. Security and confidence achieved by the internal No-Flowback Valves and soft d...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Inquire...
Integrated closure system provides security you can feel as the plastic fasteners lock into place and is both easy to close, empty and clean....
Medicine Products: